MetLife (NYSE:MET) Azioni

MetLife

MetLife is one of the largest life insurers in the us by assets and provides a variety of insurance and financial-services products. It is organized into five segments: us, Asia, Latin America, Europe/Middle East/Africa, and MetLife Holdings. The us business contributes around 50% of earnings and is broken into the group benefits segment and the retirement solutions segment. The Asia segment contributes around 22% of earnings and is mainly composed of the Japan business, with increasing contributions from India, China, and Bangladesh. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of earnings. The EMEA and MetLife Holdings segments contribute around 4% and 11% of earnings, respectively.

MetLife Inc

Metronome

Meta Platforms, Inc. - Class A Common Stock

Meta Platforms Inc

Metadium

MetagamZ

MetaPets

MetaverseX

Ramaco Resources, Inc. - Class A Common Stock

Ramaco Resources Inc

Ramaco Resources, Inc. - Class B Common Stock

Ramaco Resources, Inc. - 9.00% Senior Notes due 2026

Ramaco Resources, Inc. - 8.375% Senior Notes due 2029

Direxion Daily META Bear 1X Shares

Metis - United States Dollar

METEORIC RESORCES NL by Meteoric Resorces NL

Meteoric Resources NL

Direxion Daily META Bull 2X Shares

Roundhill Ball Metaverse ETF

ME THERAPEUTICS HLDGS by ME THERAPEUTICS HLDGS INC.

ME Therapeutics Holding Inc

MetLife, Inc. Preferred Series A Floating Rate

MetLife, Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 4.75% Non-Cumulative Preferred Stock, Series F

MetLife, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MET#NYSE">MET</a>) today announced that its board of directors has declared a second quarter 2025 common stock dividend of $0.5675 per share, an increase of 4.1% from the first quarter common stock dividend of $0.545 per share. MetLife has increased its common stock quarterly dividend at a 9.0% compound annual growth rate since 2011.
The dividend will be payable on June 10, 2025, to shareholders of record as of May 6, 2025.

News

Dividends

MetLife Hikes Q2 Common Stock Dividend by 4.1% To $0.5675/Shr From $0.545/Shr in Q1

WIIM

IBKR

MORN

SPGI

Shares of stocks in the broader financial sector are trading lower amid overall market weakness amid President Trump's criticism of Fed Chair Powell.

Wall Street kicked off the week with a rally in financial stocks, fueled by upbeat bank earnings and renewed risk appetite following Donald Trump's surprise decision to exempt new tariffs on critical <a href="https://www.benzinga.com/news/global/25/04/44785381/economist-accuses-trump-tariffs-of-wrecking-the-world-economy-predicts-ways-in-which-china-will-retaliate">tech products from China</a>.
The Financial Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>) climbed 1.6% to $47.42 by 10:10 a.m. ET, breaking above its 200-day moving average for the first time since November 2023—a move often seen by traders as a potential bullish signal. 
The sector needs to climb another 4% to fully recover the losses it incurred after the April 2 tariff announcement.
See Also: <a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44787080/goldman-sachs-cheers-china-tariff-exemptions-lifts-earnings-forecasts-for-apple-dell-hp">Goldman Sachs Cheers China Tariff Exemptions, Lifts Earnings Forecasts For Apple, Dell, HP</a>
<h3 class="wp-block-heading">Goldman Sachs Delivers A Strong Beat</h3>
The improved sentiment in financial sector's rally was led by Goldman Sachs Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>), which rose 1.1% after reporting robust quarterly results that beat Wall Street expectations on both revenue and profit.
For the first quarter of fiscal 2025, Goldman posted earnings per share of $14.12, up from $11.58 a year ago and well ahead of the $14.761 billion revenue consensus. Key revenue drivers included equities trading, which brought in $4.19 billion versus an expected $3.8 billion, and net interest income of $2.90 billion, comfortably above the $2.28 billion forecast.
The firm also announced a massive share buyback authorization of up to $40 billion, sending a strong signal of confidence in its balance sheet and forward earnings power. Loans reached $210 billion, topping the $197.61 billion estimate, while total deposits rose 8.8% quarter-over-quarter to $471 billion.
CEO David Solomon says geopolitical volatility remains a headwind but struck an optimistic tone on trade policy. "I&#8217;m encouraged by Trump&#8217;s more gradual tariff process,&#8221; he added.
<h3 class="wp-block-heading">Broader Earnings Strength Buoys Sector</h3>
Stronger-than-expected results last Friday from JPMorgan Chase &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>), Wells Fargo &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>), BlackRock Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>) and Bank of New York Mellon Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BK#NYSE">BK</a>) helped lift sentiment across the board.
JPMorgan maintains its 2025 net interest income guidance despite macroeconomic headwinds tied to trade and inflation.
Goldman analyst Richard Ramsden found this encouraging. 
"JPM continues to be in strong strategic position for a wide range of economic conditions," Ramsden said, highlighting the bank's "best-in-class capital ratios and reserves,&#8221; Ramsden said in a note. He added that if the economy weakens, JPM should trade defensively, and if the outlook improves, the bank is likely to continue gaining market share.
<h3 class="wp-block-heading">Traders Eye Technical Breakout In Financials</h3>
The breakout in the XLF fund above its 200-day moving average could signal further gains ahead. 
This level, long watched by technical analysts as a line between bullish and bearish territory, was last crossed from below to above in November 2023. Over the following one and two months, the sector gained 6.2% and 11.8%, respectively.
<h3 class="wp-block-heading">Key Gainers And What's Ahead</h3>
Banking and insurance names led Monday&#8217;s charge. Among the top gainers in the XLF ETF:
<ul>
<li>Citigroup Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>) rose 3.6% to $63.86</li>
<li>MetLife Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MET#NYSE">MET</a>) added 2.8% to $73.41</li>
<li>Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) gained 2.8% to $111.15</li>
<li>Prudential Financial Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRU#NYSE">PRU</a>) advanced 2.76% to $101.56</li>
<li>Globe Life Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GL#NYSE">GL</a>) climbed 2.56% to $122.56</li>
</ul>
Investors now turn their focus to Tuesday, when Bank of America Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) and Citigroup are scheduled to report their first-quarter earnings. 
Strong numbers from these names could reinforce the bullish momentum in financials and potentially extend the rally through the week.
Now Read: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44783143/dow-jumps-over-600-points-following-strong-bank-earnings-investor-fear-eases-fear-greed-index-remains-in-extreme-fear-zone">Dow Jumps Over 600 Points Following Strong Bank Earnings: Greed Index Remains In &#8216;Extreme Fear&#8217; Zone</a></li>
</ul>
Image: Shutterstock

Analyst Color

Earnings

Equities

Large Cap

Macro Economic Events

Sector ETFs

Econ #s

Economics

Analyst Ratings

ETFs

Bank Stocks Rebound Above 200-Day Average As Earnings Propel Dip Buyers

Barclays analyst Alex Scott maintains MetLife (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MET#NYSE">MET</a>) with a Overweight and lowers the price target from $95 to $88.

Price Target

Barclays Maintains Overweight on MetLife, Lowers Price Target to $88

Wells Fargo analyst Elyse Greenspan maintains MetLife (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MET#NYSE">MET</a>) with a Overweight and lowers the price target from $97 to $91.

Wells Fargo Maintains Overweight on MetLife, Lowers Price Target to $91

AGNC

BANC

BXMT

BXSL

COIN

COLB

CRBG

DBRG

FULT

FUTU

GGAL

Hannon Armstrong Sustainable Infrastructure Capital

HASI

HOOD

INTR

ITUB

Janus Henderson Group plc Ordinary Shares

MUFG

SMFG

STWD

UPST

Shares of companies in the broader financial services sector are trading lower as stocks pull back after surging Wednesday following President Trump's tariff pause announcement.

Morgan Stanley analyst Nigel Dally maintains MetLife (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MET#NYSE">MET</a>) with a Overweight and lowers the price target from $109 to $94.

Morgan Stanley Maintains Overweight on MetLife, Lowers Price Target to $94

Ratings for MetLife (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MET#NYSE">MET</a>) were provided by 10 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">8</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $96.1, a high estimate of $109.00, and a low estimate of $86.00. This upward trend is evident, with the current average reflecting a 1.28% increase from the previous average price target of $94.89.
<img src="https://www.benzinga.com/files/images/story/2025/1744225266_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
A clear picture of MetLife's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;-----------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Ryan Krueger &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Lowers &#x7C;Outperform &#x7C; $95.00&#x7C;$98.00 &#x7C; 
&#x7C;Brian Meredith &#x7C;UBS &#x7C;Raises &#x7C;Buy &#x7C; $98.00&#x7C;$94.00 &#x7C; 
&#x7C;John Barnidge &#x7C;Piper Sandler &#x7C;Raises &#x7C;Overweight &#x7C; $94.00&#x7C;$92.00 &#x7C; 
&#x7C;Jimmy Bhullar &#x7C;JP Morgan &#x7C;Lowers &#x7C;Overweight &#x7C; $86.00&#x7C;$88.00 &#x7C; 
&#x7C;Nigel Dally &#x7C;Morgan Stanley &#x7C;Raises &#x7C;Overweight &#x7C; $109.00&#x7C;$101.00 &#x7C; 
&#x7C;Elyse Greenspan &#x7C;Wells Fargo &#x7C;Raises &#x7C;Overweight &#x7C; $97.00&#x7C;$92.00 &#x7C; 
&#x7C;Ryan Krueger &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Lowers &#x7C;Outperform &#x7C; $98.00&#x7C;$100.00 &#x7C; 
&#x7C;Alex Scott &#x7C;Barclays &#x7C;Lowers &#x7C;Overweight &#x7C; $95.00&#x7C;$96.00 &#x7C; 
&#x7C;Jack Matten &#x7C;BMO Capital &#x7C;Announces &#x7C;Market Perform &#x7C; $97.00&#x7C;- &#x7C; 
&#x7C;Elyse Greenspan &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Overweight &#x7C; $92.00&#x7C;$93.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to MetLife. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of MetLife compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for MetLife's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of MetLife's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/MET/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on MetLife analyst ratings.</a>
<h2>Get to Know MetLife Better</h2>
MetLife is one of the largest life insurers in the us by assets and provides a variety of insurance and financial-services products. It is organized into five segments: us, Asia, Latin America, Europe/Middle East/Africa, and MetLife Holdings. The us business contributes around 50% of earnings and is broken into the group benefits segment and the retirement solutions segment. The Asia segment contributes around 22% of earnings and is mainly composed of the Japan business, with increasing contributions from India, China, and Bangladesh. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of earnings. The EMEA and MetLife Holdings segments contribute around 4% and 11% of earnings, respectively.
<h3>Financial Milestones: MetLife's Journey</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Revenue Growth: MetLife's revenue growth over a period of 3M has faced challenges. As of 31 December, 2024, the company experienced a revenue decline of approximately -3.43%. This indicates a decrease in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.
Net Margin: MetLife's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of 6.74%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 4.25%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): MetLife's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.18%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: With a high debt-to-equity ratio of 0.68, MetLife faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>The Significance of Analyst Ratings Explained</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

10 Analysts Have This To Say About MetLife

ENVA

FRHC

HLNE

LPLA

NTRS

PIPR

SNEX

VCTR

Shares of companies within the broader financial sector are trading higher following President Trump's decision to implement a 90-day pause on reciprocal tariffs for all countries except China.

Keefe, Bruyette &amp; Woods analyst Ryan Krueger maintains MetLife (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MET#NYSE">MET</a>) with a Outperform and lowers the price target from $98 to $95.

Keefe, Bruyette & Woods Maintains Outperform on MetLife, Lowers Price Target to $95

MetLife's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MET#NYSE">MET</a>) short percent of float has fallen 12.98% since its last report. The company recently reported that it has 6.42 million shares sold short, which is 1.14% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.82 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>MetLife Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744052417_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for MetLife has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing MetLife's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, MetLife's peer group average for short interest as a percentage of float is 2.63%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

Peering Into MetLife's Recent Short Interest

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Below are some instances of options activity happening in the Financials sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>HOOD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$32.00</td>
<td>$50.0K</td>
<td>262</td>
<td>4.0K</td>
</tr>
<tr>
<td>RKT</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$22.20</td>
<td>$27.9K</td>
<td>101</td>
<td>538</td>
</tr>
<tr>
<td>COIN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$185.00</td>
<td>$25.4K</td>
<td>688</td>
<td>527</td>
</tr>
<tr>
<td>V</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$140.00</td>
<td>$36.0K</td>
<td>106</td>
<td>370</td>
</tr>
<tr>
<td>JPM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$230.00</td>
<td>$34.1K</td>
<td>3.8K</td>
<td>309</td>
</tr>
<tr>
<td>ARCC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$15.00</td>
<td>$41.6K</td>
<td>0</td>
<td>289</td>
</tr>
<tr>
<td>ALLY</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$35.00</td>
<td>$27.6K</td>
<td>1.1K</td>
<td>173</td>
</tr>
<tr>
<td>MET</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/20/26</td>
<td>$65.00</td>
<td>$79.0K</td>
<td>491</td>
<td>103</td>
</tr>
<tr>
<td>FUTU</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$110.00</td>
<td>$31.2K</td>
<td>417</td>
<td>18</td>
</tr>
<tr>
<td>NU</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>05/16/25</td>
<td>$15.00</td>
<td>$26.7K</td>
<td>604</td>
<td>5</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These bullet-by-bullet explanations have been constructed using the accompanying table. 
• For HOOD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>), we notice a call option trade that happens to be bearish, expiring in 10 day(s) on April 17, 2025. This event was a transfer of 100 contract(s) at a $32.00 strike. The total cost received by the writing party (or parties) was $50.0K, with a price of $500.0 per contract. There were 262 open contracts at this strike prior to today, and today 4044 contract(s) were bought and sold. 
• For RKT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RKT#NYSE">RKT</a>), we notice a put option trade that happens to be bullish, expiring in 165 day(s) on September 19, 2025. This event was a transfer of 31 contract(s) at a $22.20 strike. The total cost received by the writing party (or parties) was $27.9K, with a price of $900.0 per contract. There were 101 open contracts at this strike prior to today, and today 538 contract(s) were bought and sold. 
• For COIN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>), we notice a call option sweep that happens to be bullish, expiring in 10 day(s) on April 17, 2025. This event was a transfer of 117 contract(s) at a $185.00 strike. This particular call needed to be split into 19 different trades to become filled. The total cost received by the writing party (or parties) was $25.4K, with a price of $219.0 per contract. There were 688 open contracts at this strike prior to today, and today 527 contract(s) were bought and sold. 
• For V (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>), we notice a call option trade that happens to be bullish, expiring in 648 day(s) on January 15, 2027. This event was a transfer of 2 contract(s) at a $140.00 strike. The total cost received by the writing party (or parties) was $36.0K, with a price of $18020.0 per contract. There were 106 open contracts at this strike prior to today, and today 370 contract(s) were bought and sold. 
• Regarding JPM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>), we observe a call option trade with bearish sentiment. It expires in 74 day(s) on June 20, 2025. Parties traded 34 contract(s) at a $230.00 strike. The total cost received by the writing party (or parties) was $34.1K, with a price of $1005.0 per contract. There were 3803 open contracts at this strike prior to today, and today 309 contract(s) were bought and sold. 
• Regarding ARCC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARCC#NASDAQ">ARCC</a>), we observe a call option sweep with bearish sentiment. It expires in 165 day(s) on September 19, 2025. Parties traded 85 contract(s) at a $15.00 strike. This particular call needed to be split into 9 different trades to become filled. The total cost received by the writing party (or parties) was $41.6K, with a price of $490.0 per contract. There were 0 open contracts at this strike prior to today, and today 289 contract(s) were bought and sold. 
• For ALLY (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALLY#NYSE">ALLY</a>), we notice a put option trade that happens to be neutral, expiring in 284 day(s) on January 16, 2026. This event was a transfer of 40 contract(s) at a $35.00 strike. The total cost received by the writing party (or parties) was $27.6K, with a price of $690.0 per contract. There were 1108 open contracts at this strike prior to today, and today 173 contract(s) were bought and sold. 
• For MET (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MET#NYSE">MET</a>), we notice a put option trade that happens to be bearish, expiring in 347 day(s) on March 20, 2026. This event was a transfer of 100 contract(s) at a $65.00 strike. The total cost received by the writing party (or parties) was $79.0K, with a price of $790.0 per contract. There were 491 open contracts at this strike prior to today, and today 103 contract(s) were bought and sold. 
• For FUTU (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FUTU#NASDAQ">FUTU</a>), we notice a put option trade that happens to be bullish, expiring in 10 day(s) on April 17, 2025. This event was a transfer of 10 contract(s) at a $110.00 strike. The total cost received by the writing party (or parties) was $31.2K, with a price of $3120.0 per contract. There were 417 open contracts at this strike prior to today, and today 18 contract(s) were bought and sold. 
• Regarding NU (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NU#NYSE">NU</a>), we observe a put option trade with neutral sentiment. It expires in 39 day(s) on May 16, 2025. Parties traded 50 contract(s) at a $15.00 strike. The total cost received by the writing party (or parties) was $26.7K, with a price of $535.0 per contract. There were 604 open contracts at this strike prior to today, and today 5 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Options

ALLY

ARCC

10 Financials Stocks With Whale Alerts In Today's Session

DGICB

PMAX

ZBAO

Shares of companies within the broader financial sector are trading lower in response to President Trump's sweeping Liberation tariffs and retaliatory responses. The sector is now facing greater macroeconomic uncertainty and recession fears.

ATLC

Brighthouse Financial, Inc. - Common Stock

FTFT

KINS

KSPI

LMND

ROOT

SOFI

Shares of companies within the broader financials sector are trading lower as markets react to President Trump's announcement of sweeping tariffs.

Legal

ORCL

PINS

SNAP

U.S. Vice President Vance Says TikTok Decision Will Come Before Deadeline

UBS analyst Brian Meredith maintains MetLife (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MET#NYSE">MET</a>) with a Buy and raises the price target from $94 to $98.

UBS Maintains Buy on MetLife, Raises Price Target to $98

Piper Sandler analyst John Barnidge maintains MetLife (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MET#NYSE">MET</a>) with a Overweight and raises the price target from $92 to $94.

Piper Sandler Maintains Overweight on MetLife, Raises Price Target to $94

JP Morgan analyst Jimmy Bhullar maintains MetLife (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MET#NYSE">MET</a>) with a Overweight and lowers the price target from $88 to $86.

JP Morgan Maintains Overweight on MetLife, Lowers Price Target to $86

ARES

BBDO

BBVA

BSBR

CNCK

GDOT

HBAN

HSBC

JFIN

QFIN

TIGR

Shares of banks and financial services stocks are trading lower following greater-than-expected inflation data measured through the PCE price index for February, while personal spending missed estimates. Additionally, recent tariff announcements may be weighing on equities.

Financial giants have made a conspicuous bullish move on MetLife. Our analysis of options history for MetLife (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MET#NYSE">MET</a>) revealed 11 unusual trades.
Delving into the details, we found 45% of traders were bullish, while 0% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $68,240, and 9 were calls, valued at $284,040.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $55.0 to $92.5 for MetLife over the recent three months. 
<h3>Volume &amp; Open Interest Development</h3>
In today's trading context, the average open interest for options of MetLife stands at 196.67, with a total volume reaching 547.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in MetLife, situated within the strike price corridor from $55.0 to $92.5, throughout the last 30 days.
<h3>MetLife Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742330739_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MET</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$12.8</td>
<td>$12.6</td>
<td>$12.6</td>
<td>$92.50</td>
<td>$35.2K</td>
<td align="right">190</td>
<td align="right">30</td>
</tr>
<tr>
<td>MET</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/20/26</td>
<td>$10.6</td>
<td>$10.3</td>
<td>$10.3</td>
<td>$87.50</td>
<td>$32.9K</td>
<td align="right">0</td>
<td align="right">33</td>
</tr>
<tr>
<td>MET</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>12/17/27</td>
<td>$34.4</td>
<td>$29.5</td>
<td>$31.99</td>
<td>$55.00</td>
<td>$31.9K</td>
<td align="right">400</td>
<td align="right">10</td>
</tr>
<tr>
<td>MET</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/17/27</td>
<td>$31.6</td>
<td>$29.1</td>
<td>$31.6</td>
<td>$55.00</td>
<td>$31.6K</td>
<td align="right">400</td>
<td align="right">62</td>
</tr>
<tr>
<td>MET</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>12/17/27</td>
<td>$33.9</td>
<td>$29.1</td>
<td>$31.6</td>
<td>$55.00</td>
<td>$31.6K</td>
<td align="right">400</td>
<td align="right">22</td>
</tr>
</tbody>
</table>

<h3>About MetLife</h3>
MetLife is one of the largest life insurers in the us by assets and provides a variety of insurance and financial-services products. It is organized into five segments: us, Asia, Latin America, Europe/Middle East/Africa, and MetLife Holdings. The us business contributes around 50% of earnings and is broken into the group benefits segment and the retirement solutions segment. The Asia segment contributes around 22% of earnings and is mainly composed of the Japan business, with increasing contributions from India, China, and Bangladesh. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of earnings. The EMEA and MetLife Holdings segments contribute around 4% and 11% of earnings, respectively.
After a thorough review of the options trading surrounding MetLife, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Where Is MetLife Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 2,932,011, with MET's price down by -0.63%, positioned at $81.64.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 43 days.</li>
</ul>
<h3>What The Experts Say On MetLife</h3>
A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $103.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Morgan Stanley continues to hold a Overweight rating for MetLife, targeting a price of $109. 
&#x2A; An analyst from Wells Fargo persists with their Overweight rating on MetLife, maintaining a target price of $97. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for MetLife, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Markets

MetLife Options Trading: A Deep Dive into Market Sentiment

Press Releases

AM Best Affirms Credit Ratings of MetLife, Inc. and Its Life/Health Subsidiaries

Economic Concerns Lower U.S. Workforce Health and Productivity, Raising Need for Employee-Employer Trust: New MetLife Study

MetLife Xcelerator Hits 4.5 Million Active Consumers and Surpasses $200M in Premiums

AM Best Assigns Issue Credit Rating to MetLife, Inc.'s New Subordinated Notes

MetLife Announced as 2025 CIO 100 Award Winner

Plan Sponsors Reaffirm Commitment to Workforce Retirement Benefits, According to New MetLife Study

MetLife Named to Fortune's 2025 List of 100 Best Companies to Work For®

MetLife to Hold Conference Call for First Quarter 2025 Results

MetLife Teams up with SKYGEN to Transform Dental Provider Digital Experience and Credentialing

Comments

MetLife

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO